Comparative economic analysis of magnetic bead-based and legacy processes for mAb manufacturing

Manufacturing monoclonal antibodies (mAbs) is a complex and costly process, but what if we could simplify it while saving money and boosting efficiency? Explore how magnetic bead-based processes can transform downstream mAb production. By consolidating cell removal and product capture into a single magnetic separation step, these novel approaches significantly reduce manufacturing costs, improve facility throughput, and enhance process efficiency. These findings highlight the potential of magnetic bead-based workflows to revolutionize mAb production with economic and sustainability benefits.